Evidence map›Paper›PMID 35578172›Full record

ArticleBMC bioinformatics2022

Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein.

Reji Manjunathan, Vijayalakshmi Periyaswami, Kartik Mitra, Arokiaraj Sherlin Rosita, Medha Pandya, Jayaraman Selvaraj, Lokesh Ravi, Nalini Devarajan, Mukesh Doble

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Validation of a Traditional Medicine,Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Impact ofMolecules (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Reji Manjunathan *Department of Genetics, Dr. ALM Post Graduate Institute of Basic Medical Sciences, Taramani Campus, University of Madras, Chennai, Tamil Nadu, India. rejimanjunath@gmail.com.
Vijayalakshmi Periyaswami *Department of Biotechnology and Bioinformatics, Holy Cross College, Bharathidasan University, Trichy, Tamil Nadu, India.
Kartik MitraBioengineering and Drug Design Lab, Department of Biotechnology, Indian Institute of Technology Madras, Chennai, Tamil Nadu, India.
Arokiaraj Sherlin RositaDepartment of Bioinformatics, Bishop Heber College (Autonomous, Bharathidasan University), Tiruchirapalli, Tamil Nadu, India.
Medha PandyaKPES Science College, Maharaja KrishnakumarSinhiji Bhavnagar University, Gujarat, India.
Jayaraman SelvarajSaveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India.
Lokesh RaviDepartment of Botany, St. Josephs College, Bangalore, Karnataka, India.
Nalini DevarajanCentral Research Laboratory, Meenakshi Ammal Dental College, Maduravoyal, Chennai, Tamil Nadu, India. nalinikrishu@gmail.com.
Mukesh DobleBioengineering and Drug Design Lab, Department of Biotechnology, Indian Institute of Technology Madras, Chennai, Tamil Nadu, India. mukesh.doble0@gmail.com.
Bharathidasan University · INSaveetha University · INBhavnagar University · INIndian Institute of Technology Madras · INMeenakshi Ammal Dental College and Hospital · INUniversity of Madras · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Transmembrane Serine Protease 2 (TMPRSS2) of human cell plays a significant role in proteolytic cleavage of SARS-Cov-2 coronavirus spike protein and subsequent priming to the receptor ACE2. Approaching TMPRSS2 as a therapeutic target for the inhibition of SARS-Cov-2 infection is highly promising. Hence, in the present study, we docked the binding efficacy of ten naturally available phyto compounds with known anti-viral potential with TMPRSS2. The aim is to identify the best phyto compound with a high functional affinity towards the active site of the TMPRSS2 with the aid of two different docking software. Molecular Dynamic Simulations were performed to analyse the conformational space of the binding pocket of the target protein with selected molecules.

resultsDocking analysis using PyRx version 0.8 along with AutoDockVina reveals that among the screened phyto compounds, Genistein shows the maximum binding affinity towards the hydrophobic substrate-binding site of TMPRSS2 with three hydrogen bonds interaction ( - 7.5 kcal/mol). On the other hand, molecular docking analysis using Schrodinger identified Quercetin as the most potent phyto compound with a maximum binding affinity towards the hydrophilic catalytic site of TMPRSS2 ( - 7.847 kcal/mol) with three hydrogen bonds interaction. The molecular dynamics simulation reveals that the Quercetin-TMPRSS complex is stable until 50 ns and forms stable interaction with the protein ( - 22.37 kcal/mol of MM-PBSA binding free energy). Genistein creates a weak interaction with the loop residues and hence has an unstable binding and exits from the binding pocket.

conclusionThe compounds, Quercetin and Genistein, can inhibit the TMPRSS2 guided priming of the spike protein. The compounds could reduce the interaction of the host cell with the type I transmembrane glycoprotein to prevent the entry of the virus. The critical finding is that compared to Genistein, Quercetin exhibits higher binding affinity with the catalytic unit of TMPRSS2 and forms a stable complex with the target. Thus, enhancing our innate immunity by consuming foods rich in Quercetin and Genistein or developing a novel drug in the combination of Quercetin and Genistein could be the brilliant choices to prevent SARS-Cov-2 infection when we consider the present chaos associated with vaccines and anti-viral medicines.

Indexed as

COVID-19 Drug TreatmentSpike Glycoprotein, CoronavirusAntiviral AgentsGenisteinHumansMolecular Docking SimulationQuercetinSARS-CoV-2Serine EndopeptidasesVirus InternalizationAntiviral AgentsGenisteinQuercetinSerine EndopeptidasesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2TMPRSS2 protein, humanBioinformatics toolsMolecular dockingMolecular dynamicsPhyto compoundsSARS-Cov-2 coronavirusTransmembrane serine protease 2

Identifiers

PMID35578172
PMCPMC9108711
OpenAlexW4280532670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.